Study type and setting
thalassemia, Thalassemia
THALASSEMIA, THALASSEMIA
This randomized controlled trial study was conducted on patients with thalassemia referring to the Kerman Thalassemia Center in Kerman, Iran in 2022. The study setting was the Kerman Thalassemia Center that provided transfusion and health care services for patients with thalassemia from different parts of Kerman province. Kerman is located in the southeast of Iran.